05 August 2019 : Clinical Research
Increased Expression of Serine Hydroxymethyltransferase 2 (SHMT2) is a Negative Prognostic Marker in Patients with Hepatocellular Carcinoma and is Associated with Proliferation of HepG2 Cells
DOI: 10.12659/MSM.915754
Med Sci Monit 2019; 25:5823-5832
HTML version available soon